Pds Biotech Announces Acceptance Of Abstract On Combination Of Pds0301 With Docetaxel In Metastatic Prostate Cancer For Oral Presentation By The National Cancer Institute At Cytokines 2023

  • William Figg

Press/Media

Period17 Jul 2023

Media coverage

1

Media coverage

  • TitlePds Biotech Announces Acceptance Of Abstract On Combination Of Pds0301 With Docetaxel In Metastatic Prostate Cancer For Oral Presentation By The National Cancer Institute At Cytokines 2023
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date17/07/23
    PersonsWilliam Figg
View all 1
View less